INVESTORS & MEDIA
Corporate Governance
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| Nov 06, 2006 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,905 | $22.25 |
| Nov 06, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 393
|
Director, Chief Exec Officer & President, Ten Percent Owner | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 11,685 | $22.25 |
| Nov 06, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 393
|
Director, Chief Exec Officer & President, Ten Percent Owner | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 5,301 | $22.25 |
| Nov 06, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 393
|
Director, Chief Exec Officer & President, Ten Percent Owner | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 47,535 | $22.25 |
| Nov 06, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 393
|
Director, Chief Exec Officer & President, Ten Percent Owner | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 31,493 | $22.25 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 592
|
SVP, Therap & Clin Prog Dev | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 9,612 | $20.12 |
| Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 592
|
SVP, Therap & Clin Prog Dev | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,939 | $20.12 |
| Oct 17, 2006 |
Director
Trans History: 402
|
Director | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 5,531 | $17.85 |
| Mar 09, 2006 |
Director
Trans History: 368
|
Director | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 4,717 | $16.76 |
| Feb 03, 2006 |
SVP, PreclinDevel & Biomol Sci
Trans History: 592
|
SVP, PreclinDevel & Biomol Sci | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 10,843 | $16.40 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.